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1. Introduction 
Reactive oxygen species (ROS) include a wide variety of molecules and free radicals derived 
from molecular oxygen. O2 being highly electrophilic can be reduced by one electron at a 
time producing relatively stable intermediates, such as superoxide anion (O2¯), precursor 
of most ROS and a relevant mediator in many biological reactions. Dismutation of O2¯  
produces hydrogen peroxide (H2O2), which, in turn, may be fully reduced to water or 
partially reduced to hydroxyl radical (OH), one of the strongest oxidants in nature. The 
formation of OH is catalyzed by reduced transition metals. On the other hand, superoxide 
anion is able to reduce transition metals and intensify in this way hydroxyl generation. In 
addition, O2¯ may react with other radicals, in particular, with nitric oxide (NO) in a 
reaction controlled by the rate of diffusion of both radicals. The product, peroxynitrite, is 
very powerful oxidant. The oxidants derived from NO have been recently called reactive 
nitrogen species (RNS). Oxidative stress is an expression used to describe various 
deleterious processes resulting from an imbalance between the formation and elimination of 
ROS and/or RNS by antioxidant defenses. While small fluctuations in the steady-state 
concentration of these oxidants play an important role in intracellular signaling, 
uncontrolled increase in their concentration produces free radical-mediated chain reactions, 
which indiscriminately target proteins, lipids, polysaccharides, and DNA. Mitochondria are 
a major source of ROS, converting as much as 0.2-2% of molecular oxygen to superoxide as a 
by-product of the electron transfer activity (Wittenberg & Wittenberg, 1989; Alvárez et al., 
2003). Other enzymatic sources of ROS include NADPH oxidases, located on the cell 
membrane of polymorphonuclear cells, macrophages, endothelial and other cells,  and 
cytochrome P450-dependent oxygenases, along with the proteolytic conversion of xanthine 
dehydrogenase to xanthine oxidase, which produces both O2¯ and H2O2.  
Mitochondria’s critical role in cardiomyocyte survival and death has become an exciting 
finding in the field of cardiac biology. Indeed, it is accepted that mitochondrial dysfunction 
plays a crucial role in the pathogenesis of multiple cardiac diseases, mainly due to the 
imbalance of the fine interplay between aerobic metabolism, calcium homeostasis, and ROS 
production. Reactive oxygen species generated in the mitochondria, unless adequately 
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neutralized, cause mitochondrial oxidative stress and, through reactions with 
polyunsaturated fatty acids, form lipid hydroperoxides and unsaturated aldehydes that 
propagate among cellular compartments and react with proteins and nucleic acids. In the 
myocardium, the oxidative stress cascade impairs several functions, like mitochondrial 
biogenesis, fatty acid metabolism, ionic homeostasis, and antioxidant defense mechanisms, 
leading to diminished cardiac energetic efficiency, altered bioenergetics, apoptosis and 
degradation. Besides the obvious relevance of mitochondria in energy production, new 
processes like mitochondrial fusion and fission are reported to be linked to ROS generation 
and now are included in the cast of key players in cardiac disease. In this  chapter, we 
explore the mechanisms of mitochondrial dysfunction driven by ROS generation associated 
with the pathophysiology of cardiovascular diseases. 
2. Mitochondrial reactive oxygen species generation 
The standard reduction potential for the conversion of molecular oxygen to O2¯   is -0.160 V 
(Wood, 1987). Given the highly reducing intramitochondrial environment, various 
respiratory components, including complexes I and III of the mitochondrial respiratory 
chain (Paradies et al., 2001; Tompkins et al., 2006),  flavoproteins (Prosser et al., 2011), iron-
sulfur clusters (Napoli et al., 2006), and ubisemiquinone (Wen & Garg, 2008) are 
thermodynamically capable to donate one electron to oxygen. Moreover, most steps in the 
respiratory chain involve single-electron reactions, further favoring the monovalent 
reduction of oxygen. On the other hand, the mitochondrion possesses various antioxidant 
defenses designed to eliminate both O2¯   and H2O2. As a result, the steady state 
concentrations of O2¯ and H2O2 have been estimated to be around 1 x 10-10 M and 5 x 10-9 
M, respectively (Cadenas & Davies, 2000). Mitochondrial sources of O2¯   include several 
respiratory complexes and individual enzymes. Superoxide formation occurs on the outer 
mitochondrial membrane, in the matrix, and on both sides of the inner mitochondrial 
membrane (Table 1, Figure  1). While superoxide anion generated in the matrix is mainly 
eliminated in that compartment, part of the O2¯   produced in the intermembrane space 
may be carried to the cytoplasm via voltage-dependent anion channels (Han et al., 2003). 
The relative contribution of every site to the overall O2¯ production varies from organ to 
organ and also depends on whether mitochondria are actively respiring (State 3) or if the 
respiratory chain is highly reduced (State 4) (Barja, 1999). Complex III appears to be 
responsible for most of the O2¯   produced in heart mitochondria (Turrens & Boveris, 1980; 
Turrens et al., 1982), although Complex I is thought to be the primary source of ROS in a 
variety of pathological scenarios ranging from ageing to Parkinson’s disease (Betarbet et al., 
2002; Sherer et al., 2003a). The rate of O2¯ formation by the respiratory chain is controlled 
primarily by mass action law, increasing both when electron flow slows down (the 
concentration of electron donors, R is higher) and when the concentration of oxygen 
increases1 (Turrens et al., 1982). 
 d[O2]/dt= k [O2] [R] (1) 
The electron flow through the respiratory chain establishes an H+ gradient across the inner 
mitochondrial membrane, used to drive ATP synthesis through the ATP synthase complex 
(Complex V). In the absence of ADP, the movement of H+ through ATP synthase is ceased 
and the H+ gradient builds up causing slowdown of electron flow and reduction of the 
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respiratory chain (State 4). As a result, the physiological steady state concentration of O2¯ 
formation increases. The formation of O2¯ may be further increased in the presence of 
certain inhibitors (for example rotenone, which inhibits Complex I, or antimycin an inhibitor 
of Complex III), which cause those carriers upstream from the site of inhibition to become 
fully reduced. In Complex I, the primary source of O2¯ appears to be one of the iron-sulfur 
clusters, whereas in Complex III, most of O2¯  results from ubisemiquinone auto-oxidation, 
both on the outer and inner sides of the inner mitochondrial membrane (Table 1). 
 
 
Table 1. Compartmental localization of the main mitochondrial sources of superoxide anion. 
Modified from Turrens, 2003. 
Although O2¯ production increases as the respiratory chain becomes more reduced, not all 
mitochondrial inhibitors have this effect. Most of the production of O2¯ by Complex III is 
actually inhibited if electron flow between the Rieske Fe–S protein and oxygen is blocked, 
for example by myxothiazol, cyanide or cytochrome c depletion (Turrens et al., 1985). This 
inhibitory effect indicates that O2¯ must be produced as a result of the autoxidation of 
semiquinone (Q), an intermediate produced in Complex III during the Q-cycle 
(Trumpower, 1990; Figure 2). Coenzyme Q is fully reduced and converted to ubiquinol 
(QH2) in the inner side of the mitochondrial membrane and then migrates to the outer side 
of the inner membrane carrying two protons that become part of the pool needed to sustain 
ADP phosphorylation. Once on the outer side of the membrane, one electron is transferred 
to cytochrome c1 (via the Rieske Fe–S protein), resulting in the formation of Q. In a second 
cycle, a new QH2 transfers one of its electrons to the iron-sulphur protein (ISP) and then to  
cytochrome c1, whereas the second electron reduces cytochrome b566 and then cytochrome 
b540 (Turrens et al., 2003). This second electron reduces the Q produced in the first cycle, 
yielding QH2. Despite the high efficiency of redox reactions in the Q cycle, some electrons 
leak and react with oxygen producing O2¯ (Figure 1).  
Another modulator of mitochondrial ROS production is the membrane potential (m), thus 
it has been reported that both, uncouplers and uncoupling proteins (UCPs), minimize ROS 
production by enhancing proton leak and providing a negative feedback loop for 
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mitochondrial ROS production. A direct impact of ROS on the glutathionylation status of 
UCPs has been invoked to explain the activation of such proteins (Mailloux & Harper, 2011). 
 
Fig. 1. Electron flow in the Q-cycle. Ubiquinone (Q) is reduced by electrons transferred from 
NADH or succinate producing ubiquinol (QH2). The reduced form undergoes a two-cycle 
reoxidation in which the semiquinone (Q) is a stable intermediate that transfers electrons 
to oxygen via the Rieske iron-sulfur protein (ISP), cytochrome c1 (c1) and cytochrome c (c). 
The terminal oxidase catalyzes the oxidation of reduced cytochrome c and the concomitant 
four-electron reduction of one O2 molecule producing water. Superoxide may be produced 
on both sides of the inner membrane via the autoxidation of Q, but the contribution of each 
pool has not yet been determined. 
Special mention is worth about how Ca2+ modulates mitochondrial ROS generation. The 
primary role of this cation in mitochondria is the stimulation of oxidative phosphorylation 
by allosteric activation of pyruvate dehydrogenase, isocitrate dehydrogenase, -
ketoglutarate dehydrogenase, as well as other proteins of the phosphorylating machinery 
(Brooks et al., 2004). Thus, the stimulation of oxidative phosphorylation would enhance ROS 
production, as mitochondria are being forced to work faster and to consume more O2. 
Experimental observations are diverse, overall it appears that physiological [Ca2+]m has no 
direct effect on respiratory chain function or oxidation/reduction process, however 
pathological mitochondrial Ca2+ overload can lead to ROS increase. Possible mechanisms 
include Ca2+ stimulated increase of metabolic rate; Ca2+ stimulated nitric oxide production, 
which inhibits complex IV;  Ca2+ induced cytochrome c dissociation that would inhibit the 
distal respiratory chain; Ca2+ induced cardiolipin peroxidation and Ca2+ induced 
mitochondrial permeability transition pore opening (Peng & Jou, 2010).  
On the other hand, simultaneous formation of O2¯ and nitric oxide can produce 
peroxynitrite, a very strong oxidant and nitrating agent. Nitric oxide is a vasodilator 
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resulting from the convertion of arginine to citrulline, in a reaction catalyzed by a family of 
NADPH-dependent enzymes called nitric oxide synthases. It has been reported that the 
mitochondrial matrix contains a unique form of nitric oxide synthase (Alvarez et al., 2003). 
Although its physiological role is still unclear, the formation of nitric oxide in mitochondria 
may have important pathological consequences, as it binds to the heme group of 
cytochrome oxidase, inhibiting respiration (Poderoso et al., 1996). ROS are also produced 
within mitochondria at sites other than the inner mitochondrial membrane (Dowrakowski et 
al., 2008), by proteins such as monoamine oxidase (MAO) and p66Shc (reviewed in Di Lisa 
et al., 2009).  
3. Antioxidant systems in mitochondria 
Mammalian mitochondria possess a multi-leveled ROS defense network of enzymes and 
non-enzymatic antioxidants. Thus, constantly generated ROS, essential for normal cellular 
physiology and signaling process, are maintained at specific levels by intrinsic antioxidant 
defenses, avoiding oxidative stress. In healthy mitochondria, ROS contention is driven by 
manganese-dependent superoxide dismutase (MnSOD), gluthatione peroxidase (GPx), 
thioredoxin (TrxSH2) and thioredoxin reductase (TrxR), peroxiredoxin (Prx), and 
glutaredoxin (Grx), as well as water- and lipid-soluble antioxidants, i.e. vitamins C, ǂ-
tocopherol (ǂ-toc), reduced glutathione (GSH), and melatonin. It has been proposed that 
under certain circumstances, the mitochondrial respiratory chain can also contribute to 
mitochondrial antioxidant defense. 
3.1 Non-enzymatic antioxidants   
The tripeptide GSH  is the main non-protein molecule, containing reactive thiol (-SH) 
groups, with scavenging properties, that provides an abundant source of reducing equivalents 
(Stowe & Camara, 2009). GSH reacts with hydroxyl radical (OH), hypochlorous acid (HOCl), 
peroxyl radical (RO2●), carbon-centered radicals, and peroxynitrite anion (ONOO-) producing 
thiyl radical (GS●), which potentially generates O2¯ among other ROS (Ježek & Hlavatá, 2005). 
Despite its exclusive synthesis in the cytosol, GSH is distributed in intracellular organelles, 
including the endoplasmic reticulum (RE), nucleus, and mitochondrion (Marí et al., 2009; 
Figure 2). GSH synthesis involves a two step reaction that requires ATP. Glutamate and 
cysteine are converted to Ǆ-glutamyl-cysteine in a rate-limiting reaction driven by Ǆ-
glutamylcysteine synthetase. Then, Ǆ-glutamylcysteine and glycine produce GSH by the action 
of the enzyme GSH synthetase (Figure 2). The first reaction is inhibited by GSH, a mechanism 
that regulates cellular GSH concentration (Marí et al., 2009). In the cytosol, GSH concentration 
is around 11 mM (Griffith & Meister, 1979; Mårtensson et al., 1990) and is transported into the 
mitochondrial matrix through a non-described high affinity carrier and a low affinity carrier, 
that could be the mitochondrial oxoglutarate carrier (Coll et al., 2003) or the dicarboxylate 
carrier (Lash et al., 2002). In mitochondria, GSH levels may fluctuate from 5 to 11 mM (Valko 
et al., 2007). Mitochondrial GSH plays a critical role in cell survival, as toxic cell death often 
correlates better with depletion of the mitochondrial GSH pool than with overall intracellular 
GSH depletion (Orrenius et al., 2007).  
The importance of UCPs in the control of mitochondrial ROS generation remains unclear: it 
is known that UCPs are inner membrane carriers that transfer protons across the 
mitochondrial inner membrane (MIM), by-passing ATPase (Stuart et al., 2001). A putative  
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Fig. 2. GSH synthesis and compartmentalization. GSH is synthesized by Ǆ-glutamylcysteine 
synthetase (Ǆ-GCS) and glutathione synthetase (GS) in the cytoplasm and then redistributed 
to mitochondria, nucleus, and endoplasmic reticulum. 
role in redox homeostasis control has been associated with their capacity to reduce 
mitochondrial ROS production by modulating Δm (Haines et al., 2010). In fact, UCPs 
reduce the damaging effects of ROS during cardiac ischemia/reperfusion injury (Barreiro et 
al., 2009). UCP1 isoform is involved in thermogenesis and expressed specifically in brown 
adipose tissue mitochondria, in which it confers a regulated proton leak across the inner 
membrane, whereas the physiologic functions of the other isoforms remain unclear. UCP2 
and UCP3 are present in the heart and provide cardioprotection. In rat neonatal 
cardiomyocytes, UCP overexpression confers tolerance against oxidative stress by a 
mechanism related with calcium uptake (Sack, 2006b).  
ǂ-Tocopherol and melatonin scavenge lipid peroxyl radicals much faster than these radicals 
can react with adjacent fatty acid side-chains, so they are probably the most important 
inhibitors of the free-radical chain reaction of lipid peroxidation in animals (Maroz et al., 
2009; Gavazza & Catalá, 2009). Aside from its various physiological functions, melatonin 
could acts as a scavenger of the particularly toxic OH and carbonate radical, which is 
important because of their presumed role in mitochondrial damage (Srinivasan et al., 2009, 
Hardeland & Coto-Montes, 2010). Besides, melatonin could act as an indirect antioxidant 
promoting de novo synthesis of GSH, stimulating the activity of γ-glutamylcysteine 
synthetase and also through its effects on GPx, Grx, SOD, and CAT gene expression 
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(Rodríguez et al., 2004), helping in GSH recycling and maintaining a high GSH/GSSG ratio. 
Melatonin is synthesized and released to the circulation by the pineal gland, and its 
amphiphilic properties lead to its free access to all compartments in the cell, being 
concentrated especially in the nucleus and mitochondria (Escames et al., 2010). A direct role 
of melatonin in regulation of Complex I and IV activity and in other mitochondrial functions 
has been suggested. This effect, not shared by other antioxidants, would reflect redox 
interactions with the electron transfer chain complexes, stimulating electron flow, limiting 
electron leakage, and ROS generation (Escames et al., 2010). Interestingly, it has also been 
reported that melatonin protects mitochondria from oxidative damage by preventing 
cardiolipin oxidation (Paradies et al., 2010).  
3.2 Enzymatic antioxidants 
MnSOD converts superoxide anion (O2¯) to hydrogen peroxide (H2O2) in the matrix side of 
the inner mitochondrial membrane (Liochev & Fridovich, 2010), while some O2¯ released 
into the intermembrane space is partially dismutated by copper-zinc containing superoxide 
dismutase (CuZnSOD) (Figure 3). Disruption of the MnSOD gene in mice has been  
 
Fig. 3. Mitochondrial antioxidant network. Mitochondria are normally protected from 
oxidative damage by a network of mitochondrial antioxidant systems. See text for further 
details. ǂ-toc: ǂ-tocoferol; Cyt c3+ (reduced cytochrome c) ; CuZnSOD: copper-zinc 
superoxide dismutase; Gpx: glutathione peroxidase; GSH: reduced glutathione, GSSG: 
oxidized glutathione; L-Arg: L-arginine; mtNOS: mitochondrial nitric oxide synthase, NO: 
nitric oxide; Prx3-(SH)2: peroxiredoxine 3 reduced, Prx3-S2: peroxiredoxine 3 oxidized; ROS: 
reactive oxygen species, RNS: reactive nitrogen species; Trx2-(SH)2: tioredoxine 2 reduced, 
Trx2-S2: tioredoxine oxidized. 
www.intechopen.com
 Oxidative Stress and Diseases 
 
164 
associated with early postnatal lethality (Li et al., 1995), while MnSOD overexpression was 
shown to protect mitochondrial function and block apoptosis (Holley et al., 2010). The 
activity of MnSOD should be coordinated with H2O2-removing enzymes. Thus, H2O2 
produced by MnSOD could be metabolized by Gpx, Prx, or by catalase that has been found 
in extremely small amounts in the mitochondrial matrix.  
Besides of the importance of GSH as a direct antioxidant, it participates in multiple GSH-
linked enzymatic defense systems. Among others, GSH acts as electron donor in the 
reduction of H2O2 and different hydroperoxides by GPx1 and GPx4 (Camara et al., 2011). 
Five different isoforms of GPx have been identified GPx1, GPx2, GPx3, GPx 4, and GPx 6. 
GPx1 is the major isoform and is localized predominantly in the cytosol, but a small 
proportion is also present within the mitochondrial matrix (Orrenius et al., 2007). GPx4 is a 
unique intracellular antioxidant enzyme that directly reduces peroxidized lipids produced 
in cell membranes (Nomura et al., 2000). Because GPx4 is membrane-associated, with a 
fraction localized in the intermembrane space of the mitochondria, possibly at the contact 
sites of the two membranes, and due to its small size and large hydrophobic surface it can 
interact with, and detoxify, membrane lipid hydroperoxides much more efficiently than the 
alternative pathway, phospholipase A2-GPx1 (PLA2) (Antunes et al., 1995). Hence, GPx4 is 
considered to be the primary enzymatic defense system against oxidative damage to cellular 
membranes. Accordingly, GPx4-null mice are embryonically lethal, while the heterozygotes 
are more sensitive to oxidants than wild type mice (Ran et al., 2003).  
Other mitochondrial GSH-linked enzymes are glutaredoxins (Grx), which catalyze 
glutathione-dependent dithiol reaction, reducing protein disulfides, and monothiol 
reactions reducing mixed disulfides between proteins and GSH. An interesting member of 
this family is glutaredoxin 2 (Grx2), which was cloned and found to be present as both 
mitochondrial and nuclear isoforms (Lundberg et al., 2001). Modeling suggests that the GSH 
binding site and the hydrophobic surface of Grx2 are similar to those of Grx1 (Lundberg et 
al., 2001), although Grx2 lacks one of the conserved non-active site cysteine residues of Grx1 
(Lundberg et al., 2001), hence it is more resistant to oxidants and oxidized glutathione 
(GSSG) action. Furthermore, Grx2 can be reactivated directly by thioredoxin reductase 
(TrxR) as well as by GSH (Johanson et al., 2004). GSSG is reduced by glutathione reductase 
(GR) with NADPH as a cofactor. In turn, mitochondrial NADPH can be regenerated by 
matrix dehydrogenases and by reaction of hydride ion transfer, which is proton motive 
force-dependent, utilizing intramitochondrial NADPH to reduce NADP+. Besides NADPH 
per se can serve directly as a non-enzymatic antioxidant, according to some authors (Kirsch 
& De Groot, 2001). Another potential source of disulfide reductase activity in mitochondria 
is the thioredoxin system, which includes thioredoxin 2 (Trx2) and thioredoxin reductase 
(TrxR2). Trx2 catalyzes the reduction of protein disulfides at much higher rates than Grx 
(Arner & Holmgren, 2000). This enzyme is important for life, given that disruption of the 
Trx2 gene in the homozygous mouse causes massive apoptosis and, finally, results in 
embryonic lethality (Nonn et al., 2003). Specific glutathione S-transferase (GST) isoforms: 
GSTǂ1-1, GSTǂ4-4, and GSTµ1-1, which neutralize reactive molecules such as 4-hydroxy-2-
noneal (4-HNE), incorporating GSH to the radical molecule, have been found in 
mitochondria (Raza et al., 2002).  
The intermembrane space of mitochondria contains ~0.7 mM cytochrome c (Hackenbrock et 
al., 1986) capable of superoxide removal. Cytochrome c can be alternatively reduced by the 
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respiratory chain or superoxide. A diminution in its concentration may inhibit the distal 
respiratory chain and increase ROS production. Indeed, it has been reported that upon 
cytochrome c release during apoptosis initiation, mitochondrial ROS production increases 
(Cai & Jones, 1998).   
As mentioned before, ubiquinone (Q) acts as a pro-oxidant in its semiquinone form, 
however when fully reduced it acts as an antioxidant. Ubiquinol (UQH2) contains phenolic 
hydrogen atoms that can be donated to a carbon- or oxygen centered radical, converting it to 
a non-radical molecule (Ježek & Hlavatá, 2005). Lipid peroxidation prevention by UQH2 has 
been reported (James et al., 2004). Preferential succinate oxidation can provide a tool against 
excessive accumulation of ROS by increasing the proportion of fully reduced ubiquinone. 
The antioxidant activity of UQH2 is independent from the effect of ǂ-tocopherol (Ernster et 
al., 1992), which acts as a chain-breaking antioxidant, inhibiting the propagation of lipid 
peroxidation (Maroz et al., 2009). Even more, UQH2 can efficiently sustain the effect of ǂ-
tocopherol by regenerating it from the tocopheroxyl radical, which otherwise must rely on 
water-soluble agents such as ascorbate (vitamin C) (Ernster & Forsmark-Andree, 1993).  
4. Oxidative stress and cardiovascular diseases 
The pathological role of increased mitochondrial ROS in heart disease has been established 
from studies in gene-modified mice with altered mitochondrial antioxidant levels. Deletion 
of mitochondrial thioredoxin reductase 2 is embryonically lethal in mice because of 
impaired hematopoiesis and impaired cardiac function (Conrad et al., 2004). Fatal dilated 
cardiomyopathy in mice is developed after complete deletion of mitochondrial Mn 
superoxide dismutase (Li et al., 1995). In contrast, attenuated left ventricular remodeling 
after myocardial infarct was observed in transgenic mice overexpressing mitochondrial 
peroxiredoxin III (Matsushima et al., 2006) or glutathione peroxidase (Shiomi et al., 2004). 
Also, mice with a mitochondrial-targeted overexpression of catalase have a prolonged life 
span and improved cardiac function (Schriner et al., 2005).  
 A critical role of intracellular Ca2+ overload and oxidative stress in the genesis of myocyte 
dysfunction is well established in cardiovascular diseases like atherosclerosis, hypertension, 
ischemia/reperfusion damage, cardiac hypertrophy, and heart failure (HF). In general, Ca2+ 
overload can be induced by direct effect of ROS on Ca2+ handling proteins or indirectly, by 
inducing membrane lipid peroxidation (Santos et al., 2011). Recent evidence suggests that 
redox modification of ryanodine receptor (RyR2) may contribute to abnormal Ca2+ handling 
in disease states. RyR2 dysfunction with an increase in diastolic Ca2+ leak from the 
sarcoplasmic reticulum (SR) may reduce calcium transients and contribute to a reduced 
contractile force in the failing heart, as well as an increased likelihood of arrhythmia 
(González et al., 2010). In humans, increased cytosolic calcium ([Ca2+]c) has been related 
with augmented oxidative stress in atherosclerosis. A growing body of evidence indicates 
that the production of ROS is tightly linked with Angiotensin II-induced action. In this 
respect, a causative link between superoxide production and hypertension has been 
established in experiments in which SOD reduced blood pressure by 50 mm Hg in vascular 
smooth muscle cells (VSCM) from Angiotensin II-infused rats (Laursen et al., 1997). Much 
less attention has been paid to other reactions catalyzed by ROS. However, it is known that 
ATPase activity and inhibition of ATP-independent Ca2+ binding are severely depressed in 
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sarcolemmal membranes exposed to hydrogen peroxide and Fe2+ (Kukreja et al., 1992, 
Kaneko et al., 1989). In addition, augmented levels of iron pool in atherosclerotic lesions 
suggest that iron-catalyzed formation of free radicals may take place in the development of 
this pathology (Yuan & Li, 2003). High-fat diets stimulate stress response (heat shock 
protein 70) and signal transduction genes (Ras, MAPK1), inhibiting SOD and GPx gene 
expression. These effects could be prevented by scavengers of peroxides and antioxidant 
supplementation of the high-fat diet and caloric restriction (Rosier & Saes, 2006). 
5. Mitochondrial dysfunction 
Mitochondrial myopathies were described in the early 1960s, when systematic 
ultrastructural and histochemical studies revealed excessive proliferation of abnormally 
looking mitochondria in muscle of patients with weakness or exercise intolerance (Shy & 
Gonatas, 1964). Mitochondrial dysfunction, reflected in the structure, function and number 
of mitochondria within the cardiomyocyte, leads to diminished energy production, loss of 
myocyte contractility, altered electrical properties, and eventual cardiomyocyte cell death 
(Capetanaki, 2002). In addition, cardiotoxic stimuli often lead to excessive production of 
ROS and to Ca2+ overload in the mitochondrial matrix (Ragoni & Condolini, 2009). 
Evidences for a pathological role of mitochondrial ROS comes from studies in animal 
models of myocardial infarction, in which increased mitochondrial ROS production was 
observed, accompanied by decreases in mtDNA copy numbers, in mitochondrial-encoded 
gene transcripts, and in related enzymatic activities (complexes I, III, and IV), and from 
studies of genetically modified animals. Overexpression of Prx-3 (a mitochondrial 
antioxidant protein) improved post-myocardial infarction left ventricular function by 
restoring mitochondrial activity and DNA copy numbers (Matsushima et al., 2006). Other 
examples are studies in mice with complete deletion of mitochondrial MnSOD, which 
developed severe fatal dilated cardiomyopathy (Li et al., 1995). Decreased vascular SOD 
activities have also been associated with increased susceptibility to ischemia/reperfusion 
mediated damage; whereas overexpression of mitochondrial antioxidants increased cardiac 
tolerance to ischemia (Madamanchi, et al., 2005). Recently, the causal role of mitochondrial 
ROS in Angiotensin II-induced cardiomyopathy was shown by the observation that mice 
that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type 
peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial 
damage induced by angiotensin II (Dai et al., 2011). Monoamine oxidase (MAO) has been 
shown to play a prominent role in myocardial injury caused by post-ischemic reperfusion 
(Bianchi et al., 2005a) and to contribute to the maladaptive evolution from myocardial 
hypertrophy to heart failure (Kaludercic et al., 2010). MAO-mediated ROS production has 
been related with serotonin-induced myocyte hypertrophy in vitro (Bianchi et al., 2005b) and in 
mitogenic signaling induction by a process that may involve the activation of the 
metalloproteinase MMP-2, in smooth muscle cells (Coatrieux et al., 2007). 
Mitochondria isolated from hearts of rabbits exposed to hypercholesterolemic diet showed 
significantly reduced respiration rates (state 3 and state 4) (Kojik et al., 2011), whereas 
increased cholesterol is related with diminution of the mitochondrial membrane potential 
and mitochondrial pore opening (Chávez et al., 1998; Martínez Abundis et al., 2007) and 
activation of apoptosis (Martínez-Abundis et al., 2009). 
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5.1 Metabolic adaptation 
Complex mechanisms have evolved to maintain the balance between myocardial O2 supply 
and O2 consumption under pathological stresses such as hypoxia, ischemia, pressure, and 
volume overload. These mechanisms induce changes in cardiomyocyte structure and/or 
function through coordinated changes in gene and protein expression and/or the activities 
of various proteins. Redox mechanisms are involved in the signaling pathways underlying 
many of these mechanisms, both via the direct effects of O2 levels in the cardiomyocyte and 
through the effects of ROS (Santos et al., 2011). Metabolically, the adult mammalian heart 
normally uses lipids as the major fuel, and mitochondria supply over 90% of the total ATP 
through ǃ-oxidation of plasma fatty acids (Opie & Sack, 2002). During hypoxia, under 
ischemia or settings of increased cardiac workload, there is a substantial increase in 
glycolytic ATP generation, which may be cardioprotective during ischemia/reperfusion by 
ensuring an adequate ATP supply for membrane and sarcoplasmic reticulum ion pumps 
(Opie & Sack, 2002; Correa et al., 2008a). Recent studies suggest that a metabolic shift to 
glycolysis is related with the redox status in the heart. NADPH has been recognized as a 
critical modulator of the antioxidant defense through the regeneration of reduced pools of 
glutathione, while G6PDH activity was shown to be of major importance for the 
maintenance of redox status, Ca2+  homeostasis, and contractile function in cardiomyocytes 
subjected to oxidative stress (Jain et al., 2003) .  
5.2 Mitochondrial biogenesis 
Mitochondrial biogenesis can be defined as a chain of events that promote growth and 
division of preexisting organelles. Mitochondrial biogenesis includes the synthesis, import 
and incorporation of proteins and lipids, as well as the replication of mitochondrial DNA 
(mtDNA). Replication and transcription of mtDNA are controlled by mtTFA (mitochondrial 
transcription factor A), and two specific transcription factors TFB1M and TFB2M 
(mitochondrial transcription factor B1/B2), an RNA polymerase (POLRMT), and a 
mitochondrial transcription termination factor (mTERF). The coordination between the 
expression of mitochondrial and nuclear genes is directed by nuclear respiratory factor 
(NRF-1 and/or NRF-2), the peroxisome proliferator-activated receptors (PPARs), estrogen 
receptor (ERR), and co-activators of peroxisome proliferator-activated receptor gamma 
(PGC-1ǂ) (Scarpulla, 2008). PGC-1ǂ is also involved in regulation of fatty acid oxidation 
(FAO) and in co-activation of ERRǂ (Figure 4). 
Mitochondrial biogenesis decreases in aging, obesity, insulin resistance, dyslipidemia, and 
hypertension, co-morbidities associated with cardiovascular diseases. Impaired activation of 
the renin-angiotensin-aldosterone system (RAAS)  has been associated with such 
pathologies (Cooper et al., 2007). In fact, elevated levels of angiotensin II (Ang II) and 
aldosterone promote alterations in insulin metabolism, endothelial dysfunction, and loss of 
myocardial function (Kim et al., 2008; Sowers et al., 2009). RAAS increases the activity of 
NADPH oxidase and stimulates ROS generation resulting in mitochondrial damage, 
decreased ATP production, diminished NO availability, and attenuated mitochondrial 
biogenesis. Clinical and experimental observations report the loss of expression of PGC-1ǂ, 
and mtTFA NRFs in hypertension (Whaley-Connell et al., 2009). In addition, down-
regulation of the mitochondrial biogenesis co-activator PGC-1ǂ and its downstream nuclear 
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factors have been associated with myocardial contractile dysfunction, intracellular Ca2+ 
mishandling, ROS accumulation, mitochondrial damage, and loss of mitochondrial density 
and mtDNA content in high-fat diet–induced obesity (Dong et al., 2007).  
 
Fig. 4. The transcriptional network that controls mitochondrial biogenesis. See text for 
further details. 
5.3 Mitochondrial ion channels 
5.3.1 Permeability transition pore 
General membrane damage secondary to ROS-mediated lipid peroxidation is one 
mechanism by which changes in mitochondrial permeability can occur; however, severe 
oxidative stress accompanied by calcium overload in the mitochondrial matrix favors the 
formation of the pathological and non-specific mitochondrial permeability transition pore 
(mPTP). Opening of the mPTP induces depolarization of the mitochondrial inner membrane 
(MIM) leading to ATP depletion and further ROS production. The increase in MIM 
permeability enhances colloidal osmotic pressure in the mitochondrial matrix ultimately 
leading to matrix swelling and rupture of the mitochondrial outer membrane (MOM). 
Rupture of the MOM results in release of pro-apoptotic proteins from the mitochondrial 
intermembrane space to the cytoplasm initiating both caspase-dependent and caspase-
independent apoptosis. Permeabilization of the MOM may also occur due to formation of 
non-selective channels induced by translocation of pro-apoptotic Bcl-2 family proteins to 
www.intechopen.com
 Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases 
 
169 
mitochondria. Due to its central role in cell death triggering, the mPTP represents a potential 
therapeutic target in some cardiovascular diseases. Studies performed over 20 years have 
demonstrated that acute cardiac ischemia followed by reperfusion damage is associated 
with mPTP opening (Arteaga et al., 1992; Griffiths & Halestrap, 1993;  Chipuk et al., 2006; 
Lucken-Ardjomande et al., 2008; Halestrap and Pasdois, 2009). Furthermore, 
pharmacological and conditional inhibition of mPTP formation significantly improved 
cardiac function reducing ischemic injury and myocardial infarction size in animal models  
(Argaud et a., 2005; Hausenloy & Yellon, 2003; Correa et al., 2008b) and in patients 
(Shanmuganathan et al., 2005; Piot et al., 2008). mPTP opening also causes cell death in 
isolated endothelial and vascular smooth muscle cells. Indeed, atherosclerosis is exacerbated 
when mitochondrial antioxidant defenses are hampered and a decrease in mitochondrial 
ROS formation reduces atherogenesis. 
Regulation of the mPTP by a variety of signaling molecules and cellular metabolites and ions 
is a complex process, and mPTP formation ultimately depends on the balance between factors 
favoring and inhibiting pore opening (Figure 5). The precise metabolic role of mPTP formation  
 
Fig. 5. Metabolic inducers and inhibitors of mPTP opening in cardiac ischemia/reperfusion 
and tumorigenesis. ANT, adenine nucleotide translocase; CK, creatine kinase; CyP-D, 
cyclophilin D; HK, hexokinase; MIM, mitochondrial inner membrane; MOM, mitochondrial 
outer membrane; Pi, inorganic phosphate; PBR, peripheral benzodiazepine receptor; SOD, 
superoxide dismutase; VDAC, voltage-dependent anion channel. 
under physiological conditions is still being debated; reverse pore opening with a low 
conductance may be attributed to regulation of mitochondrial Ca2+. Low conductive mPT-
induced matrix swelling and increased mitochondrial Ca2+ can regulate ATP synthesis 
through the tricarboxylic acid cycle, electron transport chain, and oxidative 
phosphorylation. Induction of mitochondrial permeability transition (mPT) in response to 
pathological stresses can also be regulated with the signaling protein kinases: PKA, PKCε 
www.intechopen.com
 Oxidative Stress and Diseases 
 
170 
(protein kinase Cε) and GSK-3ǃ (glycogen synthase kinase-3), which interact with the 
voltage-dependent anion channel (VDAC) (Bera et al., 1995; Baines et al, 2003; Javadov et al., 
2009).  
5.3.2 Structure of the mPTP complex 
Although the crucial role of mPTPs in pathological conditions has been intensively studied 
in the heart, brain, and liver (Chipuk et al., 2006; Bernardi et al., 2006; Robertson et al., 2009), 
the actual molecular composition of the mPTP complex remains unclear. Until recently, 
three proteins had been accepted as key structural components of this megachannel: 
adenine nucleotide translocase (ANT), cyclophilin D (CyP-D), and the voltage-dependent 
anion channel (VDAC) located in the MIM, in the matrix and in the MOM, respectively. 
However, recent studies from different groups have questioned the molecular identity of the 
mPTP. A new model of the mPTP consisting of a phosphate carrier and ANT has been 
proposed where Ca2+ sensitivity of the pore is regulated by CyP-D binding to the phosphate 
carrier (Leung et al., 2008). Many studies have provided strong evidence that CyP-D plays a 
major regulatory role in mPTP formation (Baines et al., 2005; Nakagawa et al., 2005). 
Mitochondria isolated from CyP-D knockout mice were desensitized to the onset of the 
mPT, and required much higher concentrations of Ca2+ to induce pore opening compared to 
wild type animals, which is consistent with the role of CyP-D to regulate Ca2+-mPTP 
interactions  (Nakagawa et al., 2005). Recent studies on transgenic mice questioned the role 
of ANT and VDAC as essential components of the mPTP suggesting a regulatory, rather 
than structural role in pore formation. 
5.3.3 mPTP formation in cardiac Ischemia/Reperfusion (I/R) 
mPTP opening has been examined extensively in cardiac pathological conditions, mostly in 
I/R (Chipuk et al., 2006; Correa et al., 2007; Halestrap & Pasdois, 2009). Acute I/R does not 
affect the expression of mPTP compounds due to its short duration, although it induces 
conformational changes in essential mPTP proteins, modifying their interactions with the 
pore effectors in the cytoplasm and mitochondrial matrix. Although many factors that 
induce pore opening are present during ischemia, including ATP depletion, Ca2+ overload, 
increased phosphate and ROS levels, it has been demonstrated that pore opening occurs 
during reperfusion rather than during ischemia (Griffiths and Halestrap, 1995). This is 
explained, in part, by the acidic conditions resulting from lactate and other acidic 
intermediates accumulation in the mitochondrial matrix. We and others demonstrated that 
delayed pHi recovery during reperfusion exerts beneficial effects on post-ischemic cardiac 
function, associated with improved mitochondrial function and inhibition of mPTP opening 
(Javadov et al., 2008; Correa et al., 2008a). In this regard, inhibition of the Na+/H+ exchanger 
1(NHE-1) may be a promising therapeutic strategy against I/R damage (Linz & Busch, 2003; 
Karmazyn et al., 2001). mPTP opening causes mitochondrial uncoupling, thereby ATP is 
hydrolyzed rather than synthesized in the post-ischemic heart  leading to myocardial death 
(Correa et al., 2005). mPTP opening also increases in Ca2+-induced cardiomyopathy 
(Nakayama et al., 2007), in diabetic cardiomyopathy (Oliveira et al., 2003), in heart failure 
following myocardial infarction (Javadov et al., 2005), and in intracoronary 
microembolization (Sharov et al., 2007). 
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5.3.4 Mitochondrial KATP channels 
Mitochondrial ATP-sensitive potassium channels (mK+ATP) were described about 20 years 
ago in mitoplasts obtained from rat liver mitochondria. First advances in mK+ATP  research 
demonstrated that different drugs stimulate the opening of mK+ATP channels decreasing 
mitochondrial potential (Δm) and that mK+ATP channels are involved in mechanisms 
regulating cell volume (Garlid, 1988). Latter, it was observed that bradykinin (Yang et al., 
2004), opioids (Jang et al., 2008), and adenosine (Kin H, 2005), activate signaling cascades 
that induce the opening of mK+ATP and provide cardioprotection against 
ischemia/reperfusion injury. Recently a causative link between the opening of mK+ATP and 
cardioprotection conferred by post-conditioning has been proposed. Garlid et al. (2008) 
suggested that post-conditioning induces protection via an early redox-sensitive 
mechanism, followed by persistent mK+ATP activation. A complex signaling system 
involving mitochondrial PKCε 1 and 2 may prevent the formation of the mPTP. The putative 
signaling cascade includes the activation of Gi protein-coupled receptors and cGMP-
dependent protein kinase (PKG). At mitochondrial level, this kinase binds to a hypothetic 
receptor, called "R1" in the mitochondrial outer membrane. This receptor may 
phosphorylate  PKCε 1 (Jaburek et al., 2006), which, in turn, phosphorylates the mK+ATP 
channel favoring its opening. Once activated, the entry of K+ may produce alkalinization of 
the mitochondrial matrix and promote ROS production by Complex I. ROS could activate 
the mitochondrial matrix PKCε 2, and prevent the formation of mPTP, reducing cell death 
and infarction size (Costa et al., Garlid et al., 2009) (Figure 6).  
Other proposals have been invoked to explain cardioprotection. One hypothesis is that K+ 
flow into the matrix may depolarize the inner membrane and reduce the driving force that 
sustains Ca2+ overload (Holmuhamedov et al., 1991; Murata et al., 2001). However, although 
Ca2+ reduction in the mitochondrial matrix may reduce mPTP opening in the post-ischemic 
heart, it is difficult to explain how a small depolarizing effect generated by activation of 
mK+ATP channels could avoid Ca2+-overload. Another assumption is that discrete 
mitochondrial swelling associated with K+ flow would change the architecture and 
respiratory control of mitochondria, creating a state of mitochondrial “super-efficiency” 
(Garlid, 2000). Whatever the mechanism involved in mK+ATP opening, its association with 
myocardial protection is clear. 
6. Programmed cell death and autophagy 
ROS/RNS can cause cell death by non-physiological (necrotic) or regulated pathways 
(apoptotic) in many cardiovascular diseases such as atherosclerosis, ischemic heart disease, 
heart failure, stroke, hypertension, and diabetes. The mechanisms by which ROS/RNS cause 
or regulate apoptosis typically are caspase-dependent and include the activation of 
membrane receptors, Bcl-2 family proteins, and mitochondrial dysfunction. Autophagy, a 
caspase-independent mechanism of cell death that protects cells against oxidative damage 
and is involved in the degradation and recycling of oxidized proteins and damaged 
organelles in cells, yields amino acids for de novo protein synthesis or energy provision 
(Nishida et al., 2009). While programmed cell death participation in cardiovascular diseases 
is well established, insights into caspase-independent mechanisms of cell death have 
emerged recently. 
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Fig. 6. Intramitochondrial signaling pathways. The pathways leading to mK+ATP opening, 
ROS production, and MPT inhibition are shown. 
6.1 Apoptotic mitochondrial pathway  
Mitochondria contain diverse pro-apoptotic factors within their intermembrane space, such 
as cytochrome c, apoptosis-inducer factor, and Smac ⁄ Diablo, which are released and 
propagate the death cascade. Two different pores have been described as pathways for 
cytochrome c release (reviewed in Kinally & Antonsson, 2007). The first one is the 
mitochondrial apoptosis-induced channel (MAC) formed by Bax and VDAC proteins 
(Shimizu et al., 2000). There are also reports indicating that only Bax-forming channels could 
account for cytochrome c release (Kuwana et al., 2002). In this sense, the contribution of Bax 
channels to cytochrome c release after reperfusion has been explored by Bombrun et al., 
2003. A second possible pathway described for cytochrome c release is the mPTP. These 
proteins could be assembled into a continued unspecific channel, promoting mitochondrial 
swelling, MOM rupture, and pro-apoptotic proteins release (Figure 7).  
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Fig. 7. Simplified model of cellular apoptotic pathways. Specific ligands bind to death 
receptors, activating initiator and executioner caspases. In the mitochondrial pathway, 
several stimuli are processed favoring membrane permeabilization and the release of pro-
apoptogenic factors as cytochrome c, AIF, and Smac/DIABLO to the cytosol, through 
membrane pore forming proteins, such as BAK/BAX or as a consequence of the mPTP 
opening. Once in the cytosol, cytochrome c and APAF-1 bind to caspase-9, activating 
caspase-3. The extrinsic pathway could activate the mitochondrial pathway, through the Bcl-
2 family member (Bid) that promotes BAX and BAK oligomerization.  
Overexpression of antioxidant proteins in several models sustains the relevance of oxidative 
stress in cardiomyocyte apoptosis. Catalase, glutathione peroxidase 1, metalothionein, 
mitochondrial glutaredoxin-2, and peroxiredoxin 2  over- expression reduce apoptosis and 
improve contractile dysfunction after ischemia/reperfusion injury (Shiomi et al., 2004;  
Nagy et al., 2008;  Zhao et al., 2009). As indicated, oxidative stress may activate the intrinsic 
apoptotic pathway in cardiomyocytes through multiple mechanisms, such as the induction 
of mPTP opening, DNA damage-induced, translocation of Bax and Bad to the mitochondria, 
and caspase activation. However, an alternative mode of oxidative stress-induced activation 
of the intrinsic apoptotic pathway may also involve induction of the ER stress response, 
leading to caspase-12 activation and/or Ca2+-dependent opening of the mPTP (Foo et al., 
2005). Catecholamines, angiotensin II, prostaglandin F2ǂ, or endothelin-1, which interact 
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with G-protein coupled receptors and induce cardiomyocyte hypertrophy, may also induce 
apoptosis. A well characterized mechanism is a Gǂq-mediated PKC-dependent 
transcriptional upregulation of the Bcl-2 family member Nix, which activates the 
mitochondrial death pathway (Yussman et al., 2002)  
6.2 Autophagy 
Autophagy is a physiological process that is necessary for cell survival and maintains stable 
levels of nutrients to sustain cellular homeostasis. It is also involved in various 
pathophysiological processes, and shows increased activity in response to extracellular and 
intracellular stimulation such as nutrient starvation and hypoxia. During autophagy, 
cytoplasmic constituents are sequestered into the autophagosome, a closed double 
membrane vacuole that eventually fuses with a lysosome. In the new structure, named 
autolysosome, the contents are degraded and recycled for protein synthesis (Cuervo, 2004). 
ROS act as signaling molecules in the early events of autophagy induction. If the pro-
survival attempt fails, ROS cause cell death which, depending on the experimental context, 
involves either the autophagic or the apoptotic pathway. Mitochondria are both the major 
source of intracellular ROS and, at the same time, targets of ROS. An enhanced oxidative 
stress may activate a signaling cascade involving the PKCǃ-dependent phosphorylation of 
p66 protein and its translocation to the mitochondrial matrix. Damaged mitochondria are 
degraded by a specialized form of autophagy, called mitophagy, in which mitochondrial 
calcium plays an active role. Normally calcium homeostasis is tightly regulated and occurs 
at ER-mitochondria contacts where microdomains of high calcium concentration are 
present. This event causes a variety of responses depending on the amount of Ca2+ increase, 
from stimulation of metabolism and ATP production to ROS production, mPTP opening, 
and apoptosis (Figure 8). In this respect, recent data have proposed a role of p66Shc in 
mediating the response of mitochondria to ROS-induced apoptosis or autophagy 
(Mammucari & Rizzuto, 2010).  
Autophagy increases in response to acute myocardial ischemia (AMI), chronic myocardial 
ischemia, heart failure, and cardiomyopathy degeneration (Cuervo, 2004). The effect of 
autophagy upregulation is under debate, as some studies have demonstrated that it leads to 
myocyte death after ischemia/reperfusion (Valentim et al., 2006), but others indicate that 
autophagy has a cardioprotective effect during myocardial ischemia. Three mechanisms are 
invoked to explain protection: 1) generation of free amino acids and fatty acids that 
contributes to maintain the mitochondrial energy supply, improving cell survival (Matsui et 
al., 2007), 2) elimination of disordered structural proteins, harmful to cardiac myocytes, and 
3) removal of damaged mitochondria. In human myocardial depression associated to 
endotoxemia, Hickson-Bick et al. (2008) described that mitochondrial biogenesis observed in 
cardiomyocytes may reflect an effort to replace the mitochondria eliminated by autophagy. 
In HL-1 cells subjected to oxidative stress, the induction of autophagy by rapamycin 
suppressed ROS production and protected cells against death (Yuan et al., 2009). These 
results are consistent with the notion that autophagy is a protective mechanism in this 
setting and limits the production of harmful ROS, either by removing damaged 
mitochondria or by supporting de novo glutathione biosynthesis through the delivery of 
amino acids.  
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Fig. 8. Signaling pathways, regulating mitochondrial function. ROS production is induced 
by oxidative stress, which activates a signaling cascade involving the PKCǃ-dependent 
phosphorylation of p66 its translocation to the mitochondrial matrix. Mitochondria are also 
targets of ROS damage. Damaged mitochondria are removed by mitophagy, a specialized 
form of autophagy, which is regulated by different pathways. 
7. Mitochondrial fission and fusion 
Mitochondria are highly dynamic organelles that undergo constantly fusion and fission as 
part of their normal function (Detmer & Chan, 2007). These two opposite processes are 
accurately coordinated and necessary for proper morphology and function and are thought 
to play critical roles during development, cell division, and apoptosis (Cerveny et al., 2007; 
Chan, 2006). Disruption of mitochondrial fission and fusion has been linked to the 
development and progression of some diseases. 
Mitochondrial fusion facilitates the exchange of materials between mitochondria for the 
maintenance of functional mitochondria, whereas mitochondrial fission contributes to the 
elimination of damaged mitochondrial fragments through mitophagy and contributes to the 
proper distribution of mitochondria in response to the local demand for ATP. Multiple 
proteins have been identified to mediate mitochondrial fission and fusion processes (Chan, 
2006). These two opposing processes are regulated by the mitochondrial fusion proteins, 
mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2, Fzo1 in yeast) (Eura et al., 2003), and optic atrophy 
protein 1 (Opa1, Mgm1 in yeast) (Cipolat et al., 2004), and the mitochondrial fission proteins 
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dynamin-related protein 1 (Drp1, Dnm1 in yeast) (Frank et al., 2001; Smirnova et al., 2001; 
Ingerman et al., 2005), and human mitochondrial fission protein 1 (hFis1) (Yoon et al., 2003). 
The balance between mitochondrial fusion and fission within a cell can be disrupted by a 
myriad of factors, including oxidative stress (Frank et al., 2001) and simulated ischemia (Brady 
et al., 2006), and has also been linked to aging (Kowald & Kirkwood, 2011) (Figure 9). 
 
Fig. 9. Mitochondrial fission and fusion. Mitochondrial fission involves the action of Drp1, 
which can self-assemble into polymeric spirals and is recruited into the mitochondrial 
membrane by hFis1 and Mdv1/Caf4. Drp1 polymers wrap around the mitochondrion and 
constrict the membrane until fission occurs. Mitochondrial fusion involves the interaction of 
Mfn1 and Mfn2 proteins located in the outer mitochondrial membrane of two mitochondria 
until outer membranes fuse, consequently, inner mitochondrial membrane fusion occurs 
through interaction of Opa1 proteins. See text for further details.  
7.1 Mitochondrial fusion 
Data on fission and fusion proteins’ role in heart diseases are scarce. Recently it has been 
reported that cardiac myocyte mitochondria, lacking the fusion protein Mfn2, are 
pleiomorphic and show enlarged morphopology. Consistent with an underlying mild 
mitochondrial dysfunction, Mfn2-deficient mice display modest cardiac hypertrophy 
accompanied by slight functional deterioration (Papanicolau et al., 2011). Expression of 
OPA1 is decreased in both human and rat failing hearts, which show small and fragmented 
mitochondria indicative of decreased fusion. OPA1 mRNA levels did not differ between 
failing and normal hearts, suggesting post-transcriptional control, possibly through 
degradation by proteases activated by ATP (Baricault et al., 2007). 
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7.2 Mitochondrial fission 
It has been suggested that defects in mitochondrial fusion and fission processes are 
responsible for abnormal mitochondrial morphologies observed in many cardiac diseases. In 
cultured neonatal ventricular myocytes, inhibition of mitochondrial fission, by over-
expressing a dominant-negative mutant form of Drp1, prevents ROS production, 
mitochondrial permeability transition pore opening, and subsequent cell death after 
ceramide treatment (Parra et al., 2008). An increase in the level of cytosolic Ca2+ induced by 
thapsigargin (Tg) causes cardiac mitochondrial fission associated to ROS generation in a 
Drp1-dependent pathway (Hom et al., 2010). Because calcium overload is a common feature 
in heart failure (HF), this may increase mitochondrial fission and dysfunction, thus further 
contributing to the decrease in the metabolic demand of the heart and increasing its injury. 
8. Conclusion 
Mitochondrial redox signaling is paramount to the maintenance of cardiomyocyte 
homeostasis. Therefore, oxidative deregulation of mitochondrial key players, like mK+ATP, 
mPTP, ionic transporters, metabolism enzymes, and apoptotic machinery, has enormous 
impact on cardiovascular function. Intense research is devoted to obtain a better 
understanding of the complex regulatory mechanisms ruling these systems and to enable 
the development of more specific therapeutic strategies for heart diseases. In addition, 
fascinating links are beginning to be discovered between mitochondrial function and cardiac 
physiology and diseases in the context of diverse signaling mechanisms. Besides, proteins 
with previously known function, like those driving mitochondrial fusion and fission, are 
now reported to have emergent functions in intracellular calcium homeostasis, apoptosis, 
and vascular smooth muscle cell proliferation, all, key issues in cardiac disease. These 
processes broaden the traditional role in energy production undertaken by mitochondria 
and provide new directions for research in cardiovascular diseases.  
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